212 related articles for article (PubMed ID: 10525315)
1. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
Brenden N; Rietz C; Böhme J
Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
[TBL] [Abstract][Full Text] [Related]
2. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
[TBL] [Abstract][Full Text] [Related]
3. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
4. Disease-protected major histocompatibility complex Ea-transgenic non-obese diabetic (NOD) mice show interleukin-4 production not seen in susceptible Ea-transgenic and non-transgenic NOD mice.
Brenden N; Böhme J
Immunology; 1998 Sep; 95(1):1-7. PubMed ID: 9767450
[TBL] [Abstract][Full Text] [Related]
5. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
Leijon K; Hillörn V; Bergqvist I; Holmberg D
J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
[TBL] [Abstract][Full Text] [Related]
6. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
Serreze DV; Leiter EH
J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
[TBL] [Abstract][Full Text] [Related]
7. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
8. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
[TBL] [Abstract][Full Text] [Related]
9. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved.
Mathieu C; Casteels K; Bouillon R; Waer M
J Immunol; 1997 Feb; 158(3):1453-7. PubMed ID: 9013991
[TBL] [Abstract][Full Text] [Related]
10. Differential MHC expression requirements for positive selection of separate TCR Vb families.
Brenden N; Böhme J
Immunogenetics; 1999 Jan; 49(1):1-6. PubMed ID: 9811963
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
[TBL] [Abstract][Full Text] [Related]
12. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
13. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
[TBL] [Abstract][Full Text] [Related]
14. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
Rabinovitch A; Suarez-Pinzon WL; Sorensen O
J Autoimmun; 1996 Oct; 9(5):645-51. PubMed ID: 8933280
[TBL] [Abstract][Full Text] [Related]
16. Development of insulin-dependent diabetes mellitus in [(NOD + BALB/c) --> NOD] mixed allogeneic bone marrow chimeras.
Takao F; Yasumizu R; Than S; Ohnishi-Inoue Y; Sigiura K; Inaba M; Ikehara S
Immunobiology; 1995 Nov; 194(4-5):376-89. PubMed ID: 8749231
[TBL] [Abstract][Full Text] [Related]
17. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
Serreze DV; Gaskins HR; Leiter EH
J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
[TBL] [Abstract][Full Text] [Related]
18. Early appearance of donor-type antigen-presenting cells in the thymuses of 1200 R radiation-induced bone marrow chimeras correlates with self-recognition of donor I region gene products.
Longo DL; Davis ML
J Immunol; 1983 Jun; 130(6):2525-7. PubMed ID: 6406592
[TBL] [Abstract][Full Text] [Related]
19. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
20. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
